swiss life sciences trend analysis 2014

14
Swiss Life Sciences Trend Analysis 2014

Upload: hector-hebert

Post on 01-Jan-2016

38 views

Category:

Documents


4 download

DESCRIPTION

Swiss Life Sciences Trend Analysis 2014. About Us. The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. www.biotechgate.com - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Swiss Life Sciences Trend Analysis 2014

Swiss Life Sciences Trend Analysis 2014

Page 2: Swiss Life Sciences Trend Analysis 2014

About Us

The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. www.biotechgate.com

The Swiss Life Sciences Database is a part of the global Biotechgate and is brought to you in partnership with Swiss Biotech Association, Biotechnet, BaselArea and Life Sciences Zurich. www.swisslifesciences.com

Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. www.venturevaluation.com

Page 3: Swiss Life Sciences Trend Analysis 2014

Overview of the Swiss Life-science Industry

2014 Statistics

Total Biotech Companies 346

Medtech companies 258

Pharma companies 46

Investor companies 36

Public / Non-Profit Organizations / Medical Facilities 209

Other Life sciences companies 927

Percentage of Publicly Owned Companies 3%

Venture Capital Raised (2013) USD 401m

Venture Capital Raised (2012) USD 249m

Number of Technologies 163

Licensing Opportunities 128

Page 4: Swiss Life Sciences Trend Analysis 2014

Number of Employees

Page 5: Swiss Life Sciences Trend Analysis 2014

Company Ownership

Page 6: Swiss Life Sciences Trend Analysis 2014

Overview of the Swiss Biotechnology Industry

2013 Statistics

2014 Statistics

345 Total Biotech Companies 346

102 Biotech - Therapeutics 101

178 Biotech - R&D Services 172

65 Biotech - Other 73

89% Percentage of SME's 94%

4% Percentage of Publicly Owned Companies 4%

USD 153m (2012)

Financing/Capital RaisedUSD 325m

(2013)

171 Licensing Opportunities 100

Page 7: Swiss Life Sciences Trend Analysis 2014

Company Foundation Timeline

Page 8: Swiss Life Sciences Trend Analysis 2014

Key Activities of Biotechnology Companies

Page 9: Swiss Life Sciences Trend Analysis 2014

Biotech products - Breakdown by Indication

Page 10: Swiss Life Sciences Trend Analysis 2014

Products in the Pipeline – Three-year Trend

Page 11: Swiss Life Sciences Trend Analysis 2014

Venture Financing in Switzerland – Half-yearly Data

Page 12: Swiss Life Sciences Trend Analysis 2014

Major Biotech Financing Rounds (H2 2013 – H1 2014)

Company Sector USD M

NovImmune SA Biotech – Therapeutics & Diagnostics 67

Covagen AG Biotech – Therapeutics & Diagnostics 47

Biocartis SA Biotechnology - R&D Services 40.5

ADC Therapeutics, Inc

Biotech – Therapeutics & Diagnostics 40

Anokion SA Biotechnology - R&D Services 37.2

Page 13: Swiss Life Sciences Trend Analysis 2014

About Biotechgate

Biotechgate contains over 30’000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data.

To register for free or learn more about the different subscription options, please visit www.biotechgate.com.

Page 14: Swiss Life Sciences Trend Analysis 2014

Terms of Use

The “Swiss Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at www.biotechgate.com. The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof.

The use of the figures and graphs provided in this report is free of charge for any presentations as long as www.biotechgate.com is clearly cited as the source. For all other uses please contact us for terms and conditions.

Biotechgatec/o Venture Valuation VV AGKasernenstrasse 11 +41 (43) 321 86 608004 Zurich [email protected] www.venturevaluation.com